The crucial role of ribonucleotide reductase M2 (RRM2) enzyme in cancer occurrence and progression has been well‐established, but its specific function and significance in medulloblastoma (MB) remains largely unknown. This evidence concerns the gene RRM2 and medulloblastoma.